SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Pharmaceuticals’ arm gets EIR from USFDA for manufacturing facility

09 Sep 2024 Evaluate

Suven Pharmaceuticals’ Wholly Owned Subsidiary -- Casper Pharma’s formulations manufacturing facility has received the Establishment Inspection Report (EIR) from United States Food & Drug Administration (USFDA). 

The USFDA has categorized the inspection as Voluntary Action Indicated (VAI) and has deemed it as closed under 21 CFR 20.64(d)(3).

Suven Pharmaceuticals is a bio-pharmaceutical company, incorporated with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.

Cohance Lifesciences Share Price

362.25 0.35 (0.10%)
22-Apr-2026 09:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1662.75
Dr. Reddys Lab 1211.30
Cipla 1224.65
Zydus Lifesciences 925.75
Lupin 2290.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×